Toxicology of toluene diisocyanate

Applied Occupational and Environmental Hygiene

Volumn 17, Issue 12, 2002, Pages 846-855

  Collins, Michael A ^a  

^a Gilbert International Ltd   (United Kingdom)

Author keywords

Carcinogenicity; Development; Reproduction; Review; TDI; Toxicity

Indexed keywords

CORN OIL; SOLVENT; TOLUENE DIISOCYANATE;

ACIDITY; BODY WEIGHT; CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CARCINOGENICITY; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DEGRADATION; DISEASE SEVERITY; EMBRYOTOXICITY; FETOTOXICITY; GENOTOXICITY; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; HYDROLYSIS; HYPERPLASIA; LARYNX; LUNG; METABOLISM; MORBIDITY; MUTAGENICITY; NONHUMAN; NOSE IRRITATION; OCCUPATIONAL EXPOSURE; PREDICTION; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; RHINITIS; SURVIVAL; TERATOGENICITY; TOXICOKINETICS; TRACHEA; WEIGHT GAIN;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; AIR POLLUTANTS, OCCUPATIONAL; ANIMALS; CARCINOGENS; DISEASE MODELS, ANIMAL; FEMALE; GUINEA PIGS; HUMANS; IRRITANTS; LETHAL DOSE 50; MALE; MICE; RATS; RATS, INBRED F344; TOLUENE 2,4-DIISOCYANATE;

EID: 0036895531     PISSN: 1047322X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10473220290107048     Document Type: Conference Paper

References (63)

1. Pemberton, D.: MDI and TDI: Vapour Pressures and Saturated Vapour Concentrations. GIL Report 2001/C. Gilbert International Ltd., Manchester, UK (2001).
2. American Conference of Governmental Industrial Hygienists (ACGIH®): Toluene-2,4-diisocyanate. In: Documentation of the Threshold Limit Values and Biological Exposure Indices, 6th Ed., pp. 1581-1589. ACGIH®, Cincinnati, OH (1991).
3. Schnorr, T.; Egilman, D.: Toluene diisocyanate and other isocyanates. In: Occupational Medicine, 2nd Ed., C. Zenz, ed., pp. 1016-1021. Year Book Medical Publishers, Chicago, IL (1988).
4. Woolrich, P.F.: Toxicology, industrial hygiene and medical control of TDI, MDI and PMPPI. Am Indus Hyg Assoc J 43(2):89-97 (1982).
5. Duprat, P.; Gradiski, D.; Marignac, B.: Irritating and allergizing power of two isocyanates, toluene diisocyanate (TDI), diphenylmethane diisocyanate (MDI). Eur J Toxicol 9(1):41-53 (1976).
6. Woolhiser, M.R.; Hayes, B.B.; Meade, B.J.: A combined murine local lymph node and irritancy assay to predict sensitization and irritancy potential of chemicals. Toxicol Methods 8(4):245-256 (1998).
7. Shiotsuka, R.N.: Sensory Irritation Study of Mondur TD-80 in Sprague-Dawley Rats. Toxicology Report 842. Mobay Corporation, Stilwell, KS (1987).
8. Sangha, G.K.; Alarie, Y.: Sensory irritation by toluene diisocyanate in single and repeated exposures. Toxicol Appl Pharmacol 50:533-547 (1979).
9. Weyel, D.A.; Rodney, B.S.; Alarie, Y.: Sensory irritation, pulmonary irritation, and acute lethality of a polymeric isocyanate and sensory irritation of 2,6-toluene diisocyanate. Toxicol Appl Pharmacol 64:423-430 (1982).
10. Zissu, D.; Binet, S.; Limasset, J.-C.: Cutaneous sensitization to some polyisocyanate prepolymers in guinea pigs. Contact Derm 39:248-251 (1998).
11. Vandebriel, R.J.; De Jong, W.H.; Spiekstra, S.W.; et al.: Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for interferon-gamma and interleukin-4. Toxicol Appl Pharmacol 162:77-85 (2000).
12. Koschier, F.J.; Burden, E.J.; Brunkhorst, C.S.; et al.: Concentration-dependent elicitation of dermal sensitization in guinea pigs treated with 2,4-toluene diisocyanate. Toxicol Appl Pharmacol 67:401-407 (1983).
13. Thorne, P.S.; Hillebrand, J.A.; Lewis, G.R.; et al.: Contact sensitivity by diisocyanates: Potencies and cross-reactivities. Toxicol Appl Pharmacol 87:155-165 (1987).
14. Estlander, T.; Keskinen, H.; Jolanki, R.; et al.: Occupational dermatitis from exposure to polyurethane chemicals. Contact Derm 27:161-165 (1992).
15. Scheerens, H.; Buckley, T.L.; Davidse, E.M.; et al.: Toluene diisocyanate-induced in vitro tracheal hyperreactivity in the mouse. Am J Respir Crit Care Med 154:858-865 (1996).
16. Scheerens, H.; Buckley, T.L.; Leusink Muis, T.; et al.: Long-term topical exposure to toluene diisocyanate in mice leads to antibody production and in vivo airway hyperresponsiveness three hours after intranasal challenge. Am J Respir Crit Care Med 159:1074-1080 (1999).
17. Pauluhn, J.: Assessment of chemicals for their potential to induce respiratory allergy in guinea pigs: A comparison of different routes of induction and confounding effects due to pulmonary hyperreactivity. Toxicol in Vitro 8(5):981-985 (1994).
18. Pauluhn, J.: Assessment of respiratory hypersensitivity in guinea pigs sensitized to toluene diisocyanate: Improvements on analysis of respiratory response. Fund Appl Toxicol 40:211-219 (1997).
19. Karol, M.H.; Tollerud, D.J.; Campbell, T.P.; et al.: Predictive value of airways hyperresponsiveness and circulating IgE for identifying types of responses to toluene diisocyanate inhalation challenge. Am J Respir Crit Care Med 149:611-615 (1994).
20. Matheson, J.M.; Lange, R.W.; Lemus, R.; et al.: Importance of inflammatory and immune components in a mouse model of airway reactivity to toluene diisocyanate (TDI). Clin Exp Allergy 31(7):1067-1076 (2001).
21. Shiotsuka, R.N.; Warren, D.L.; Halliburton, A.T.; et al.: A comparative respiratory sensitization study of 2,4- and 2,6-toluene diisocyanate using guinea pigs. Inhal Toxicol 12:605-615 (2000).
22. National Toxicology Program (NTP): Toxicology and Carcinogenesis Studies of Commercial Grade 2,4(80%)- and 2,6(20%)Toluene Diisocyanate in F344/N Rats and B6C3F1 Mice (Gavage Studies). NIH Publication No. 86-2507. U.S. Department of Health and Human Services, NTP, Research Triangle Park, NC (1986).
23. Zapp, J.A.: Hazards of isocyanates in polyurethane foam plastic production. Am Arch Indus Health 15:324-330 (1957).
24. Woolrich, P.F.: Toxicology, industrial hygiene and medical control of TDI, MDI and PMPPI. Am Indus Hyg Assoc J 43(2):89-97 (1982).
25. Rando, R.J.; Abdel-Kader, H.M.; Hammad, Y.Y.: Isomeric composition of airborne TDI in the polyurethane foam industry. Am Indus Hyg Assoc J 45(3):199-203 (1984).
26. Doe, J.E.; Horspool, G.M.: Toluene Di-Isocyanate: Acute Inhalation Toxicity in the Rat. III Report No. 10142. ICI Central Toxicology Laboratory, Macclesfield, UK (1980).
27. Duncan, B.; Scheel, L.D.; Fairchild, E.J.; et al.: Toluene diisocyanate inhalation toxicity: Pathology and mortality. Am Indus Hyg Assoc J 23(6):447-456 (1962).
28. Henck, J.W.; Kociba, R.J.; Keyes, D.G.; et al.: A 30-Day Repeated Inhalation Toxicity Study of Toluene Diisocyanate (TDI) in Laboratory Animals. III Report No. 10153. Dow Chemical Company, Midland, MI (1976).
29. Bennett, I.P.; Chart, I.S.; Doe, J.E.; et al.: Tolylene Di-Isocyanate Three-Week Inhalation Toxicity in the Rat. III Report No. 10024. ICI Central Toxicology Laboratory, Macclesfield, UK (1980).
30. Barrows, R.S.: Mutagenic Activity of Toluene, 2,4-Diisocyanate in the Salmonella/Microsome Assay. Haskell Laboratory Report No. 784-76, MR No. 2356-004. E.I. du Pont de Nemours & Co., Newark, DE (1976).
31. Seel, K.; Walber, U.; Herbold, B.; et al.: Chemical behaviour of seven aromatic diisocyanates (toluenediisocyanates and diphenylmethanediisocyanates) under in vitro conditions in relationship to their results in the salmonella/microsome test. Mutat Res 438:109-123 (1999).
32. Mackay, J.M.: Toluene Di-Isocyanate: An Evaluation in the Mouse Micronucleus Test. III Report No. 10995. ICI Central Toxicology Laboratory, Macclesfield, UK (1992).
33. Loeser, E.: Long-term toxicity and carcinogenicity studies with 2,4/2,6-toluene-diisocyanate (80/20) in rats and mice. Toxicol Lett 15:71-81 (1983).
34. Benford, D.J.; Riley, R.A.: TDI: Mutagenicity Study for the Detection of Unscheduled DNA Synthesis Ex Vivo in Hepatocytes and Lung Following a Single Exposure of Toluene Diisocyanate to Rats by Inhalation. III Report No. 10547. Bayer AG, Leverkusen, Germany (1988).
35. Benford, D.J.; Riley, R.A.: TDI: Mutagenicity Study for the Detection of Unscheduled DNA Synthesis Ex Vivo in Hepatocytes and Lung Following Exposure of Toluene Diisocyanate to Rats by Inhalation for Five Successive Days. Bayer Report R4673. Bayer AG, Wuppertal, Germany (1989).
36. Dieter, M.P.; Boorman, G.A.; Jameson, C.W.; et al.: The carcinogenic activity of commercial grade toluene diisocyanate in rats and mice in relation to the metabolism of the 2,4- and 2,6-TDI isomers. Toxicol Indus Health 6(6):599-621 (1990).
37. Schulz, C.O.: Review of the National Toxicology Program Carcinogenesis Bioassay of Toluene Diisocyanate. III Report No. 10117. Clement Associates, Arlington, VA (1983).
38. Owen, P.E.: The Toxicity and Carcinogenicity to Rats of Toluene Diisocyanate Vapour Administered by Inhalation for a Period of 113 Weeks: Addendum Report Vol. 2. III Report No. 10208. Hazleton Laboratories Europe Ltd., Harrogate, UK (1984).
39. Ader, A.W.; Carney, I.F.; Loeser, E.: Risk evaluation of chronic exposure to toluene diisocyanate based on long-term animal studies. In: 50 Years of Polyurethanes - Proceedings of the FSK/ SPI Polyurethanes World Congress, Aachen, Germany, 29 Sept2 Oct 1987, pp. 188-192. Society of the Plastics Industry, Inc., New York, NY (1987).
40. Doe, J.E.: The carcinogenic activity of commercial grade toluene diisocyanate in rats and mice in relation to the metabolism of the 2,4- and 2,6-tdi isomers. Dieter et al. [Letter to the editor.] Toxicol Indus Health 7(4):327-329 (1991).
41. Doe, J.E.; Hoffmann, H.D.: Toluene di-isocyanate: An assessment of carcinogenic risk following oral and inhalation exposure. Toxicol Indus Health 11(1):13-32 (1995).
42. Hagmar, L.; Welinder, H.; Mikoczy, Z.: Cancer incidence and mortality in the swedish polyurethane foam manufacturing industry. Br J Indus Med 50:537-543 (1993).
43. Hagmar, L.; Stroemberg, U.; Welinder, H.; et al.: Incidence of cancer and exposure to toluene diisocyanate and methylene diphenyldiisocyanate: A cohort based case-referent study in the polyurethane foam manufacturing industry. Br J Indus Med 50:1003-1007 (1993).
44. Schnorr, T.M.; Steenland, K.; Egeland, G.M.; et al.: Mortality of workers exposed to toluene diisocyanate in the polyurethane foam industry. Occup Environ Med 53(10):703-707 (1996).
45. Sorahan, T.; Pope, D.: Mortality and cancer morbidity of production workers in the united kingdom flexible polyurethane foam industry. Br J Indus Med 50:528-536 (1993).
46. Sorahan, T.; Nichols, L.: Mortality and cancer morbidity of production workers in the united kingdom flexible polyurethane foam industry: Updated findings, 1958-1998. Occup Environ Med (2002). In press.
47. Mortillaro, P.T.; Schiavon, M.: Un casa di neoplasia polmonare nel corso di una broncopneumopatia da isocianati. Med Lav 3:207209 (1982).
48. Jeffcoat, A.R.; Feldman, D.; Maarr, H.; et al.: Disposition of 2,6-Toluene Diisocyanate in Fischer 344 Rats. Project Report No. 7. Pharmacokinetics of Xenobiotics. RTI/2227/00-06P. Research Triangle Institute, Research Triangle Park, NC (1985).
49. Jeffcoat, A.R.: Absorption and Disposition of Orally Administered 2,4-Toluene Diisocyanate in the Fischer 344 Rat. Project Report No. 2. RTI/3662/02P. Research Triangle Institute, Research Triangle Park, NC (1988).
50. Timchalk, C.; Smith, F.A.; Bartels, M.J.: Route-dependent comparative metabolism of [14c]toluene 2,4-diisocyanate and [14c]toluene 2,4-diamine in fischer 344 rats. Toxicol Appl Pharmacol 124:181-190 (1994).
51. Stoltz, M.; Czarnecki, D.; Pallas, F.; et al.: Disposition and metabolism of 14c-toluene diisocyanate (TDI) following oral and inhalation exposure in rats. Toxicologist 8(1):206 Abstr 820 (1988).
52. Kennedy, A.L.; Stock, M.F.; Alarie, Y.; et al.: Uptake and distribution of 14c during and following inhalation exposure to radioactive toluene diisocyanate. Toxicol Appl Pharmacol 100:280-292 (1989).
53. Kennedy, A.L.; Wilson, T.R.; Stock, M.F.; et al.: Distribution and reactivity of inhaled 14c-labeled toluene diisocyanate (TDI) in rats. Arch Toxicol 68(7):434-443 (1994).
54. Brown, W.E.; Aul, D.J.; Stock, M.E; et al.: Comparative uptake and distribution of 14c labeled diisocyanates. Pharmacol Toxicol 73(2):63, Abstr. P1/09 (1993).
55. Kennedy, A.L.; Timchalk, C.; Brown, W.E.: Analysis of the differential reactivity of isocyanates: Effect of exposure method. In: Measuring, Understanding, and Predicting Exposures in the 21st Century - Proceedings of a Conference, Atlanta, Georgia, 18-21 Nov. 1991, E. Pellizzari, ed. Princeton Scientific Publishing, Princeton, NJ (1992).
56. Czuppon, A.B.; Marczynski, B.; Baur, X.: Detection of protein changes in serum of workers following inhalation exposure to toluene diisocyanate vapors. Toxicol Indus Health 8(6):407-413 (1992).
57. Baillie, T.A.; Kassahun, K.: Reversibility in glutathione-conjugate formation. Adv Pharm 27:163-181 (1994).
58. Day, B.W.; Jin, R.; Basalyga, D.M.; et al.: Formation, solvolysis, and transcarbamoylation reactions of bis(s-glutathionyl) adducts of 2,4- and 2,6-diisocyanatotoluene. Chem Res Toxicol 10(4): 424-431 (1997).
59. Lange, R.W.; Day, B.W.; Lemus, R.; et al.: Intracellular S-glutathionyl adducts in murine lung and human bronchoepithelial cells after exposure to diisocyanatotoluene. Chem Res Toxicol 12:931-936 (1999).
60. Lantz, R.C.; Lemus, R.; Lange, R.W.; et al.: Rapid reduction of intracellular glutathione in human bronchial epithelial cells exposed to occupational levels of toluene diisocyanate. Toxicol Sci 60:348-355 (2001).
61. Tyl, R.W.; Fisher, L.C.; Dodd, D.E.; et al.: Developmental toxicity evaluation of inhaled toluene diisocyanate vapor in CD rats. Toxicol Sci 52:248-257 (1999).
62. Tyl, R.W.; Neeper-Bradley, T.L.; Fisher, L.C.; et al.: Two-generation reproductive toxicity study of inhaled toluene diisocyanate vapor in CD rats. Toxicol Sci 52:258-268 (1999).
63. 141Ce-radiolabelled microspheres. Toxicol Appl Pharmacol 77:496-500 (1985).